This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Top Five Animal Care Stocks

This past week on "Mad Money," Jim Cramer broke down a lot of names we often hear such as Procter & Gamble (PG - Get Report) and Wal-Mart (MWT), but he also highlighted Idexx Labs (IDXX - Get Report), which he called "the Costco (COST - Get Report) of pet stocks."

That description prompted me to create a portfolio on Stockpickr of the Top Five Animal Health Care Stocks.

According to an August 2007 Business Week article, Americans spend an estimated $41 billion per year on their pets, and that figure is expected to grow at a compound annual growth rate of 12.3% for the next two years. Animal farm-care costs are about $25 billion and are rapidly growing, according to Congress' Office of Technology Assessment. To help prevent these rising costs, animal scientists are using biotechnology to develop an array of products to diagnose, treat and prevent disease in animals.

One of the most interesting areas is animal biotechnology, which has already had a profound impact on diagnostic testing. Many animal diseases are difficult to diagnose, and veterinarians often have to wait hours or days for laboratory results to confirm a diagnosis.

However, I am much more comfortable playing this trend with animal retailers and other service-oriented companies instead of investing in the more risky (yet potentially more rewarding) biotech companies.

First up is PetSmart (PETM), a retailer that also provides services in a wide market of animal care, including grooming and bathing. Also interesting here is that it also offers veterinary care services, including examinations and vaccinations, dental care, a pharmacy and surgical procedures.

With PetSmart trading near its 52-week low, and with quarterly revenue growth of 7.8% and a forward price-to-earnings (P/E) ratio of 12, the stock is a great buy here. Despite being in the midst of upgrading its warehouse management system, Goldman Sachs analyst Matthew Fassler said, "PetSmart's long-term appeal is considerable, given its niche, services business, and ongoing growth trajectory." Fassler reiterated his $34 price target in his report.

Next up is PetMed Express (PETS - Get Report), which engages in the marketing and sale of prescription and nonprescription pet medication and other health products for dogs, cats and horses. Near its 52-week low, PetMed stock offers the best reward out of all of these picks to investors.

PetMed has in place a $20 million share-buyback -- just under 10% of its market cap -- and a 15% short position . The company has $55 million in cash and zero debt.

The past two quarters the company has solidly beaten analysts' expectations both on the top and bottom lines, thus PETS could be due for a snapback. In an article for the Web site Small Business Trends, the CEO of Embrace Pet Insurance predicts, "Online veterinary pharmaceuticals will become more main stream."

To see the entire portfolio of pet stocks, check out the Top Five Animal Health Care Stocks at Stockpickr. Other stocks that make this list are VCA Antech (WOOF - Get Report), which has a forward P/E of 25, and Heska (HSKA), which lately has seen insider buying.

Please note that due to factors including low market capitalization and/or insufficient public float, we consider Heska and PetMed Express to be small-cap stocks. You should be aware that such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information, and that postings such as this one can have an effect on their stock prices.
At the time of publication, Altucher and/or his fund had no positions in stocks mentioned, although positions may change at any time.

James Altucher is president of Stockpickr LLC, a wholly owned subsidiary of and part of its network of Web properties, and a managing partner at Formula Capital, an alternative asset management firm that runs a fund of hedge funds. He is also a weekly columnist for the Financial Times and the author of Trade Like a Hedge Fund , Trade Like Warren Buffett and SuperCa$h . Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback; click here to send him an email. has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
PETM $82.98 0.04%
COST $143.99 0.00%
IDXX $71.04 0.00%
PG $81.20 0.00%
PETS $16.06 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs